Literature DB >> 17579026

The inositol 5'-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production.

Wai-Hang Leung1, Silvia Bolland.   

Abstract

Aggregation of the high-affinity IgE receptor (FcepsilonRI) on mast cells initiates signaling pathways leading to degranulation and cytokine release. It has been reported that SHIP-1 negatively regulates FcepsilonRI-triggered pathways but it is unknown whether its homologous protein SHIP-2 has the same function. We have used a lentiviral-based RNA interference technique to obtain SHIP-2 knockdown bone marrow-derived mast cells (BMMCs) and have found that elimination of SHIP-2 results in both increased mast cell degranulation and cytokine (IL-4 and IL-13) gene expression upon FcepsilonRI stimulation. Elimination of SHIP-2 from BMMCs has no effect on FcepsilonRI-triggered calcium flux, tyrosine phosphorylation of MAPKs or in actin depolymerization following activation. Rather, we observe that absence of SHIP-2 results in increased activation of the small GTPase Rac-1 and in enhanced microtubule polymerization upon FcepsilonRI engagement. Coimmunoprecipitation experiments in rat basophilic leukemia (RBL 2H3) cells show that SHIP-2 interacts with the FcepsilonRI beta-chain, Gab2 and Lyn and that unlike SHIP-1, it does not associate with SHC in mast cells. Our results report a negative regulatory role of SHIP-2 on mast cell activation that is calcium independent and distinct from the regulation by SHIP-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579026     DOI: 10.4049/jimmunol.179.1.95

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  GAB2--a scaffolding protein in cancer.

Authors:  Sarah J Adams; Iraz T Aydin; Julide T Celebi
Journal:  Mol Cancer Res       Date:  2012-08-07       Impact factor: 5.852

2.  Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.

Authors:  Wenbin Xiao; Jun-Ichi Kashiwakura; Hong Hong; Hiroki Yasudo; Tomoaki Ando; Mari Maeda-Yamamoto; Dianqing Wu; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunity       Date:  2011-06-16       Impact factor: 31.745

3.  Small interfering RNA screen for phosphatases involved in IgE-mediated mast cell degranulation.

Authors:  Juan Zhang; Mary Mendoza; Michel F Guiraldelli; Emilia Alina Barbu; Reuben P Siraganian
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

Review 4.  Signaling pathways critical for allergic airway inflammation.

Authors:  John D Colgan; Isaiah L Hankel
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-02

5.  Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.

Authors:  Hiam Abdala-Valencia; Paul J Bryce; Robert P Schleimer; Joshua B Wechsler; Lucas F Loffredo; Joan M Cook-Mills; Chia-Lin Hsu; Sergejs Berdnikovs
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

Review 6.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 7.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

8.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

9.  Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway.

Authors:  S Kamura; Y Matsumoto; J-I Fukushi; T Fujiwara; K Iida; Y Okada; Y Iwamoto
Journal:  Br J Cancer       Date:  2010-07-06       Impact factor: 7.640

Review 10.  Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells.

Authors:  Yacine Bounab; Andrew Getahun; John C Cambier; Marc Daëron
Journal:  Curr Opin Immunol       Date:  2013-05-15       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.